Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers

NCT05245669 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Male Subjects

Interventions

BIOLOGICAL: ENZ215
BIOLOGICAL: EU Sourced Prolia
BIOLOGICAL: US Sourced Prolia

Sponsor

Enzene Biosciences Ltd.

Collaborators

[object Object]